Becker's Oncology

Among prostatectomy patients, same-day discharge was associated with nearly double the odds of readmission within 30 days, according to a study published Feb. 15 in CancerMed.  Researchers from Massachusetts General Hospital and Brigham and Women’s Hospital, both based in Boston,…

Eleven individuals who have made significant contributions to cancer research, innovation and clinical care were included in Time’s third annual Time100 Health list. The list was published Feb. 11 and highlighted the 100 most influential individuals in health, including leaders…

Weston-based Cleveland Clinic Florida has tapped Manpreet Bedi, MD, as division chair of radiation oncology. Dr. Bedi most recently served as vice chair and professor of radiation oncology at Milwaukee-based Medical College of Wisconsin, according to a Feb. 12 news…

Coral Gables, Fla.-based Baptist Health South Florida has opened a cancer care facility in Key West, Fla. The center will provide infusion services as well as medical and radiation oncology care, according to a Feb. 13 news release from Baptist…

The National Institutes of Health will no longer categorize basic experimental studies involving humans (BESH) as clinical trials, according to a Jan. 29 announcement from the agency. BESH applications submitted on or after May 25, 2026, will not be subject…

Beginning in April, Boston-based Brigham and Women’s Hospital will phase out all currently contracted Dana-Farber Cancer Institute physician assistants by the end of 2026, according to a Feb. 12 Boston Globe report.  Dana-Farber, also based in Boston, is ending its…

New prostate cancer diagnoses increased 12.08% and prostate-specific antigen screenings increased 52.18% between 2021 and 2024, according to data published Feb. 12 by Epic Research.  Epic’s research division utilized data from Cosmos, a dataset created in collaboration with a community…

Patients with endometrial hyperplasia or benign uterine pathology had a 66% reduced risk of developing endometrial cancer when treated with progestins and a GLP-1 compared to patients treated with progestins alone, according to a study published Feb. 10 in JAMA…

In November, Peoria, Ill.-based OSF HealthCare named James McGee, MD, president of the system’s cancer institute. Dr. McGee grew up on a small farm in central Illinois, where limited access to care shaped his early understanding of rural healthcare gaps.…

We have entered a decisive era for U.S. cancer care. Seventy percent of people now live at least five years after a cancer diagnosis, an unprecedented milestone founded on decades of scientific research. Yet these gains are not shared equally…